Direct-to-Consumer Genetic Testing: Failure Is Not an Option

著者: Altman, RB
出版事項 2009

Personal Genomic Measurements: The Opportunity for Information Integration

著者: Altman, RB
出版事項 2013

Translational Bioinformatics: Linking the Molecular World to the Clinical World

著者: Altman, RB
出版事項 2012

Generating Genome-Scale Candidate Gene Lists for Pharmacogenomics

著者: Hansen, NT, Brunak, S, Altman, RB
出版事項 2009

Interpreting the CYP2D6 Results From the International Tamoxifen Pharmacogenetics Consortium

著者: Province, MA, Altman, RB, Klein, TE
出版事項 2014

Challenges in the Pharmacogenomic Annotation of Whole Genomes

著者: Altman, RB, Whirl-Carrillo, M, Klein, TE
出版事項 2013

Estimation of Maximum Recommended Therapeutic Dose Using Predicted Promiscuity and Potency

著者: Liu, T, Oprea, T, Ursu, O, Hasselgren, C, Altman, RB
出版年 Clin Transl Sci (2016)

Maternal–fetal and neonatal pharmacogenomics: a review of current literature

著者: Blumenfeld, YJ, Reynolds-May, MF, Altman, RB, El-Sayed, YY
出版事項 2009

Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping Array

著者: Johnson, JA, Burkley, BM, Langaee, TY, Clare-Salzler, MJ, Klein, TE, Altman, RB
出版事項 2012

Enabling the curation of your pharmacogenetic study

著者: McDonagh, E.M., Whirl-Carrillo, M., Altman, R.B., Klein, T.E
出版年 Clin Pharmacol Ther (2014)

DNATwist: A Web-Based Tool for Teaching Middle and High School Students About Pharmacogenomics

著者: Berlin, DS, Person, MG, Mittal, A, Oppezzo, MA, Chin, DB, Starr, B, Klein, TE, Schwartz, DL, Altman, RB
出版事項 2010

Pharmacogenomics Knowledge for Personalized Medicine

著者: Whirl-Carrillo, M, McDonagh, EM, Hebert, JM, Gong, L, Sangkuhl, K, Thorn, CF, Altman, RB, Klein, TE
出版事項 2012

Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels

著者: Tatonetti, NP, Denny, JC, Murphy, SN, Fernald, GH, Krishnan, G, Castro, V, Yue, P, Tsau, PS, Kohane, I, Roden, DM, Altman, RB
出版事項 2011

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing

著者: Johnson, JA, Gong, L, Whirl-Carrillo, M, Gage, BF, Scott, SA, Stein, CM, Anderson, JL, Kimmel, SE, Lee, MTM, Pirmohamed, M, Wadelius, M, Klein, TE, Altman, RB
出版事項 2011

The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response

著者: Giacomini, KM, Brett, CM, Altman, RB, Benowitz, NL, Dolan, ME, Flockhart, DA, Johnson, JA, Hayes, DF, Klein, T, Krauss, RM, Kroetz, DL, McLeod, HL, Nguyen, AT, Ratain, MJ, Relling, MV, Reus, V, Roden, DM, Schaefer, CA, Shuldiner, AR, Skaar, T, Tantisira, K, Tyndale, RF, Wang, L, Weinshilboum, RM, Weiss, ST, Zineh, I
出版年 Clin Pharmacol Ther (2007)

Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis

著者: Danese, E, Montagnana, M, Johnson, JA, Rettie, AE, Zambon, CF, Lubitz, SA, Suarez-Kurtz, G, Cavallari, LH, Zhao, L, Huang, M, Nakamura, Y, Mushiroda, T, Kringen, MK, Borgiani, P, Ciccacci, C, Au, NT, Langaee, T, Siguret, V, Loriot, MA, Sagreiya, H, Altman, RB, Shahin, MHA, Scott, SA, Khalifa, SI, Chowbay, B, Suriapranata, IM, Teichert, M, Stricker, BH, Taljaard, M, Botton, MR, Zhang, JE, Pirmohamed, M, Zhang, X, Carlquist, JF, Horne, BD, Lee, MTM, Pengo, V, Guidi, GC, Minuz, P, Fava, C
出版事項 2012